Clinical Trial Update: Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial update examines a combination regimen of Erlotinib, Docetaxel, and radiation therapy for locally advanced head and neck squamous cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Hypopharyngeal Cancer
• Laryngeal Cancer
• Nasopharyngeal Cancer
• Oral Cavity Cancer
• Oropharyngeal Cancer
• Tongue Cancer
• Verrucous Carcinoma

Drugs mentioned

• Radiation therapy
• Tarceva (erlotinib)
• Taxotere (docetaxel)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Stage III Squamous Cell Carcinoma of the Hypopharynx | Phase 1 | Status: COMPLETED